Hospital
Plumas District Hospital
Plumas District Hospital was paid $2.13M by Medicaid between Jan 2018 and Nov 2024, across 81 billing codes. Its largest line is 0450, Emergency room services — 18% of everything it billed.
33Billing provider infoPLUMAS DISTRICT HOSPITAL
QUINCY, CA 95971
QUINCY, CA 95971
33aNPI1326094269assigned 05/25/2006
33bProvider typeCritical Access Hospital
28Total paid$2.13M
24GClaims67,215
24DCodes billed81
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in California
Rank by total paid#20 of 30
Median peer was paid$3.14M
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,277 | $148K | |
| 2019 | 8,085 | $189K | |
| 2020 | 8,201 | $217K | |
| 2021 | 12,080 | $394K | |
| 2022 | 12,158 | $422K | |
| 2023 | 14,263 | $401K | |
| 2024incomplete | 6,151 | $364K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 18% | 5,818 | 5,085 | $380K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 8.4% | 1,093 | 985 | $179K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 8.1% | 2,226 | 1,884 | $173K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 7.6% | 1,110 | 1,066 | $163K |
| 99199 | Unlisted special service, procedure or report | 4.9% | 2,001 | 1,739 | $105K |
| 80053 | Comprehensive metabolic panel | 4.7% | 6,776 | 6,073 | $100K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4.3% | 1,851 | 469 | $93K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.2% | 1,584 | 1,434 | $90K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.8% | 1,469 | 1,239 | $80K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3.2% | 1,176 | 1,008 | $69K |
| 84443 | Thyroid stimulating hormone (TSH) | 3.2% | 2,806 | 2,740 | $68K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.0% | 6,379 | 5,691 | $64K |
69 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.4% | 1,705 | $51K |
| 0250 | 2.3% | 2,343 | $48K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.0% | 388 | $43K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.9% | 638 | $40K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1.8% | 2,235 | $37K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.6% | 895 | $35K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.1% | 663 | $23K |
| 87631 | 1.1% | 318 | $23K | |
| 80061 | Lipid panel | 1.0% | 1,563 | $22K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,398 | $19K |
| 97750 | <1% | 209 | $18K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 28 | $14K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,138 | $14K |
| 84484 | <1% | 876 | $14K | |
| T1999 | Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | <1% | 700 | $12K |
| 84439 | <1% | 956 | $12K | |
| 81001 | <1% | 1,886 | $9K | |
| 83690 | <1% | 1,013 | $9K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 216 | $9K |
| 99283 | Emergency room visit (moderate) | <1% | 145 | $9K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 1,516 | $9K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 259 | $8K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 347 | $8K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 91 | $7K |
| 71045 | Radiologic examination, chest; single view | <1% | 443 | $7K |
| 85027 | <1% | 795 | $6K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 126 | $5K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 894 | $5K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 228 | $4K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 32 | $4K |
| 83605 | <1% | 318 | $4K | |
| 83880 | <1% | 147 | $4K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 40 | $3K |
| 85610 | <1% | 614 | $3K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 645 | $3K |
| 87070 | <1% | 219 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,779 | $3K |
| 82550 | <1% | 369 | $3K | |
| 83735 | <1% | 379 | $3K | |
| J3490 | Unclassified drugs | <1% | 846 | $3K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 35 | $2K |
| 81003 | <1% | 546 | $2K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 205 | $2K |
| 86140 | <1% | 245 | $1K | |
| 85379 | <1% | 101 | $1K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 323 | $1K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 116 | $1K |
| 85730 | <1% | 73 | $735.58 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 31 | $594.66 |
| 81025 | <1% | 79 | $559.64 | |
| 86703 | <1% | 38 | $556.52 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 81 | $524.25 |
| 82553 | <1% | 31 | $473.06 | |
| 73030 | <1% | 24 | $423.63 | |
| 99070 | <1% | 75 | $311.63 | |
| 87040 | <1% | 30 | $262.93 | |
| 87400 | <1% | 15 | $257.81 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 17 | $237.72 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 54 | $228.93 |
| 86141 | <1% | 20 | $197.54 | |
| 99285 | Emergency room visit (most serious) | <1% | 14 | $193.79 |
| 0270 | <1% | 96 | $181.09 | |
| 82150 | <1% | 21 | $166.29 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 26 | $129.90 |
| 86592 | <1% | 24 | $107.87 | |
| 85651 | <1% | 14 | $72.40 | |
| 82570 | <1% | 13 | $61.88 | |
| A0427 | Emergency ambulance ride, advanced life support | 0% | 35 | $0.00 |
| A0425 | Ground mileage, per statute mile | 0% | 144 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKEPPLE, JEFFREY (CEO)
| Provider | Location | Paid |
|---|---|---|
| Plumas District Hospital | Quincy, CA | $10.70M |
| Plumas District Hospital | Greenville, CA | $591K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.